International Experts Reinforce Support for "Heavy Ion + Cell Therapy"

Global Experts Advance Heavy Ion-Cell Therapy Integration

On March 1st, a grand event supported by international experts to advance "heavy ion + cell therapy" quietly unfolded at the Wuwei Heavy Ion Center. Dr. Lu Meisheng from MedAbome, Inc. (USA), who boasts over 30 years of experience in the R&D, pilot production, and manufacturing of therapeutic monoclonal antibodies, led his team to visit the Wuwei Heavy Ion Center. He held discussions with our institute to explore the establishment of a cell therapy center and address matters related to "antibody drug clinical trials and cell therapy." This marked the third round of discussions between Dr. Lu, a U.S.-based Chinese scientist, and our institute on this topic, with both sides showing increasingly clear cooperation intentions.

Meanwhile, in the adjacent meeting room, Prof. Hauffe from Germany was conducting a weekly work summary. The unexpected encounter between these two international experts seemed to foretell a new leap in high technology, thereby unveiling the prelude to a new chapter of "heavy ion + cell therapy for tumors."

During this significant discussion, Dr. Lu comprehensively elaborated on the cell therapy plan for cooperation with our institute, demonstrating his firm belief and expectation for new breakthroughs in the field of tumor treatment. Prof. Hauffe, on the other hand, summarized the achievements of heavy ion therapy. During his tenure at our institute, the Wuwei Heavy Ion Center successfully completed heavy ion treatment for 1,143 patients, yielding remarkable results.

The in-depth exchange between the two experts revealed tremendous potential for cooperation. They firmly believe that the integration of heavy ion therapy and cell therapy will bring revolutionary breakthroughs and hope to tumor treatment. This fortuitous gathering brought together elites in the field of tumor treatment, an inevitable outcome of the perfect convergence of high technology.

We have every reason to believe that, with the support of international experts such as Dr. Lu Meisheng and Prof. Hauffe, a new chapter in "heavy ion + cell therapy for tumors" will be written, bringing new hope and vitality to countless tumor patients.